| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $8.3B | $7.8B | $7.0B | $6.6B | $2.6B | $2.1B | $1.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.1B | $2.0B | $1.9B | $1.7B | — | — | — | — |
| Operating Income | $1.1B | $1.1B | $1.1B | $1.1B | $1.3B | $0.8B | $1.1B | $0.6B |
| Net Income | $0.8B | $0.9B | $0.9B | $0.9B | $2.0B | $0.7B | $0.2B | $-0.0B |
| EPS (Basic) | $10.08 | $10.57 | $10.06 | $10.55 | $23.44 | $7.99 | $2.33 | $-0.33 |
| EPS (Diluted) | $10.08 | $10.57 | $10.05 | $10.53 | $23.30 | $7.93 | $2.30 | $-0.33 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.6B | $30.8B | $29.8B | $28.8B | $28.9B | $73.6B | $70.1B | $63.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.7B | $1.4B | $1.2B | $0.9B | $2.1B | $2.8B | $2.3B | $1.5B |
| Total Liabilities | $27.8B | $26.4B | $25.5B | $24.8B | $23.9B | $66.8B | $63.9B | $58.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.8B | $4.5B | $4.3B | $4.1B | $5.0B | $6.8B | $6.3B | $5.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.2B | $2.0B | $1.2B | $1.7B | $2.2B | $2.5B | $2.1B |
| Investing Cash Flow | $-0.8B | $0.1B | $0.4B | $-1.1B | $-0.4B | $-1.6B | $-3.1B | $-5.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-1.1B | $-2.0B | $-1.4B | $-2.0B | $-0.1B | $1.4B | $2.4B |